Alejandro Tamborelli, Virginia Vaschetti, Benjamín Viada, Michael López Mujica, Soledad Bollo, Diego Venegas-Yazigi, Patricio Hermosilla-Ibáñez, Gustavo Rivas, Pablo Dalmasso
{"title":"用含有苯硼酸残基的新型希夫碱官能化的多壁碳纳米管:利用响应面方法开发生物酶葡萄糖生物传感器。","authors":"Alejandro Tamborelli, Virginia Vaschetti, Benjamín Viada, Michael López Mujica, Soledad Bollo, Diego Venegas-Yazigi, Patricio Hermosilla-Ibáñez, Gustavo Rivas, Pablo Dalmasso","doi":"10.1007/s00604-024-06608-6","DOIUrl":null,"url":null,"abstract":"<div><p> An innovative supramolecular architecture is reported for bienzymatic glucose biosensing based on the use of a nanohybrid made of multi-walled carbon nanotubes (MWCNTs) non-covalently functionalized with a Schiff base modified with two phenylboronic acid residues (SB-dBA) as platform for the site-specific immobilization of the glycoproteins glucose oxidase (GOx) and horseradish peroxidase (HRP). The analytical signal was obtained from amperometric experiments at − 0.050 V in the presence of 5.0 × 10<sup>−4</sup> M hydroquinone as redox mediator. The concentration of GOx and HRP and the interaction time between the enzymes and the nanohybrid MWCNT–SB-dBA deposited at glassy carbon electrodes (GCEs) were optimized through a central composite design (CCD)/response surface methodology (RSM). The optimal concentrations of GOx and HRP were 3.0 mg mL<sup>−1</sup> and 1.50 mg mL<sup>−1</sup>, respectively, while the optimum interaction time was 3.0 min. The bienzymatic biosensor presented a sensitivity of (24 ± 2) × 10<sup>2</sup> µA dL mg<sup>−1</sup> ((44 ± 4) × 10<sup>2</sup> µA M<sup>−1</sup>), a linear range between 0.06 mg dL<sup>−1</sup> and 21.6 mg dL<sup>−1</sup> (3.1 µM–1.2 mM) (<i>R</i><sup>2</sup> = 0.9991), and detection and quantification limits of 0.02 mg dL<sup>−1</sup> (1.0 µM) and 0.06 mg dL<sup>−1</sup> (3.1 µM), respectively. The reproducibility for five sensors prepared with the same MWCNT–SB-dBA nanohybrid was 6.3%, while the reproducibility for sensors prepared with five different nanohybrids and five electrodes each was 7.9%. The GCE/MWCNT–SB-dBA/GOx-HRP was successfully used for the quantification of glucose in artificial human urine and commercial human serum samples.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":705,"journal":{"name":"Microchimica Acta","volume":"191 9","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multi-walled carbon nanotubes functionalized with a new Schiff base containing phenylboronic acid residues: application to the development of a bienzymatic glucose biosensor using a response surface methodology approach\",\"authors\":\"Alejandro Tamborelli, Virginia Vaschetti, Benjamín Viada, Michael López Mujica, Soledad Bollo, Diego Venegas-Yazigi, Patricio Hermosilla-Ibáñez, Gustavo Rivas, Pablo Dalmasso\",\"doi\":\"10.1007/s00604-024-06608-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p> An innovative supramolecular architecture is reported for bienzymatic glucose biosensing based on the use of a nanohybrid made of multi-walled carbon nanotubes (MWCNTs) non-covalently functionalized with a Schiff base modified with two phenylboronic acid residues (SB-dBA) as platform for the site-specific immobilization of the glycoproteins glucose oxidase (GOx) and horseradish peroxidase (HRP). The analytical signal was obtained from amperometric experiments at − 0.050 V in the presence of 5.0 × 10<sup>−4</sup> M hydroquinone as redox mediator. The concentration of GOx and HRP and the interaction time between the enzymes and the nanohybrid MWCNT–SB-dBA deposited at glassy carbon electrodes (GCEs) were optimized through a central composite design (CCD)/response surface methodology (RSM). The optimal concentrations of GOx and HRP were 3.0 mg mL<sup>−1</sup> and 1.50 mg mL<sup>−1</sup>, respectively, while the optimum interaction time was 3.0 min. The bienzymatic biosensor presented a sensitivity of (24 ± 2) × 10<sup>2</sup> µA dL mg<sup>−1</sup> ((44 ± 4) × 10<sup>2</sup> µA M<sup>−1</sup>), a linear range between 0.06 mg dL<sup>−1</sup> and 21.6 mg dL<sup>−1</sup> (3.1 µM–1.2 mM) (<i>R</i><sup>2</sup> = 0.9991), and detection and quantification limits of 0.02 mg dL<sup>−1</sup> (1.0 µM) and 0.06 mg dL<sup>−1</sup> (3.1 µM), respectively. The reproducibility for five sensors prepared with the same MWCNT–SB-dBA nanohybrid was 6.3%, while the reproducibility for sensors prepared with five different nanohybrids and five electrodes each was 7.9%. The GCE/MWCNT–SB-dBA/GOx-HRP was successfully used for the quantification of glucose in artificial human urine and commercial human serum samples.</p><h3>Graphical Abstract</h3>\\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":705,\"journal\":{\"name\":\"Microchimica Acta\",\"volume\":\"191 9\",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2024-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microchimica Acta\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00604-024-06608-6\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microchimica Acta","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s00604-024-06608-6","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
Multi-walled carbon nanotubes functionalized with a new Schiff base containing phenylboronic acid residues: application to the development of a bienzymatic glucose biosensor using a response surface methodology approach
An innovative supramolecular architecture is reported for bienzymatic glucose biosensing based on the use of a nanohybrid made of multi-walled carbon nanotubes (MWCNTs) non-covalently functionalized with a Schiff base modified with two phenylboronic acid residues (SB-dBA) as platform for the site-specific immobilization of the glycoproteins glucose oxidase (GOx) and horseradish peroxidase (HRP). The analytical signal was obtained from amperometric experiments at − 0.050 V in the presence of 5.0 × 10−4 M hydroquinone as redox mediator. The concentration of GOx and HRP and the interaction time between the enzymes and the nanohybrid MWCNT–SB-dBA deposited at glassy carbon electrodes (GCEs) were optimized through a central composite design (CCD)/response surface methodology (RSM). The optimal concentrations of GOx and HRP were 3.0 mg mL−1 and 1.50 mg mL−1, respectively, while the optimum interaction time was 3.0 min. The bienzymatic biosensor presented a sensitivity of (24 ± 2) × 102 µA dL mg−1 ((44 ± 4) × 102 µA M−1), a linear range between 0.06 mg dL−1 and 21.6 mg dL−1 (3.1 µM–1.2 mM) (R2 = 0.9991), and detection and quantification limits of 0.02 mg dL−1 (1.0 µM) and 0.06 mg dL−1 (3.1 µM), respectively. The reproducibility for five sensors prepared with the same MWCNT–SB-dBA nanohybrid was 6.3%, while the reproducibility for sensors prepared with five different nanohybrids and five electrodes each was 7.9%. The GCE/MWCNT–SB-dBA/GOx-HRP was successfully used for the quantification of glucose in artificial human urine and commercial human serum samples.
期刊介绍:
As a peer-reviewed journal for analytical sciences and technologies on the micro- and nanoscale, Microchimica Acta has established itself as a premier forum for truly novel approaches in chemical and biochemical analysis. Coverage includes methods and devices that provide expedient solutions to the most contemporary demands in this area. Examples are point-of-care technologies, wearable (bio)sensors, in-vivo-monitoring, micro/nanomotors and materials based on synthetic biology as well as biomedical imaging and targeting.